What is Radium-223 (Ra-223) Therapy?

Ra-223 is an alpha-emitting radiopharmaceutical used to treat bone metastases in prostate cancer. Radium mimics calcium, targeting the affected bone tissues directly.

 

What are the benefits of Ra-223 therapy?

• Pain relief from bone metastases.

• Slows disease progression.

• Improves quality of life.

 

What are the side effects of Ra-223 therapy?

The most common side effects include mild gastrointestinal disturbances and temporary anemia.